Inhibrx Biosciences, Inc. (INBX)
NASDAQ · Healthcare
Inhibrx Biosciences, Inc. Operating Income 2023–2025
Inhibrx Biosciences, Inc. annual/quarterly operating income history and growth rate from 2023 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Inhibrx Biosciences, Inc. operating income for the quarter ending September 30, 2025 was -33.8 M, a 27.75% decrease year-over-year.
- Inhibrx Biosciences, Inc. operating income for the twelve months ending September 30, 2025 was -150.9 M, a 53.12% decrease year-over-year.
- Inhibrx Biosciences, Inc. annual operating income for 2025 was -135.0 M, a 59.26% decrease from 2024.
- Inhibrx Biosciences, Inc. annual operating income for 2024 was -331.4 M, a 51.19% increase from 2023.
- Inhibrx Biosciences, Inc. annual operating income for 2023 was -219.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Inhibrx Biosciences, Inc. Operating Income — FAQ
Inhibrx Biosciences, Inc. (INBX) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Inhibrx Biosciences, Inc.'s operating income?
Inhibrx Biosciences, Inc. (INBX) reported operating income of -$135M for fiscal 2025.
Where can I see INBX's operating income history?
The chart and table above show Inhibrx Biosciences, Inc.'s operating income by year and by quarter, including the growth rate.